K. Gauger

581 total citations
9 papers, 463 citations indexed

About

K. Gauger is a scholar working on Oncology, Cancer Research and Economics and Econometrics. According to data from OpenAlex, K. Gauger has authored 9 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Cancer Research and 3 papers in Economics and Econometrics. Recurrent topics in K. Gauger's work include Breast Cancer Treatment Studies (5 papers), Cancer Treatment and Pharmacology (3 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). K. Gauger is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Cancer Treatment and Pharmacology (3 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). K. Gauger collaborates with scholars based in Germany, Netherlands and United States. K. Gauger's co-authors include Nadia Harbeck, Marion Kiechle, Manfred Schmitt, Ronald Kates, George F. Vande Woude, Thomas Richter, Beatrice S. Knudsen, Georgia Salanti, Dieter Prechtel and Anita Welk and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and Thrombosis and Haemostasis.

In The Last Decade

K. Gauger

9 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Gauger Germany 6 214 205 176 102 66 9 463
M W Büchler Switzerland 6 216 1.0× 209 1.0× 94 0.5× 88 0.9× 31 0.5× 9 456
Ryouichi Hamasuna Japan 13 125 0.6× 243 1.2× 100 0.6× 231 2.3× 34 0.5× 21 525
Christine To Canada 9 323 1.5× 391 1.9× 196 1.1× 116 1.1× 173 2.6× 11 708
Sean E. Sissons United States 8 201 0.9× 242 1.2× 145 0.8× 20 0.2× 75 1.1× 11 476
Wendy Cooper United States 8 162 0.8× 184 0.9× 87 0.5× 53 0.5× 95 1.4× 10 393
Silvana Vignati Italy 7 184 0.9× 257 1.3× 152 0.9× 53 0.5× 218 3.3× 9 489
Shutaro Ozawa Japan 6 343 1.6× 263 1.3× 126 0.7× 19 0.2× 127 1.9× 16 538
K. Hoekman Netherlands 6 128 0.6× 166 0.8× 72 0.4× 22 0.2× 60 0.9× 11 323
P.N. Munster United States 12 336 1.6× 307 1.5× 79 0.4× 31 0.3× 119 1.8× 18 584
Y Yonemura Japan 7 296 1.4× 284 1.4× 115 0.7× 41 0.4× 80 1.2× 13 516

Countries citing papers authored by K. Gauger

Since Specialization
Citations

This map shows the geographic impact of K. Gauger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Gauger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Gauger more than expected).

Fields of papers citing papers by K. Gauger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Gauger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Gauger. The network helps show where K. Gauger may publish in the future.

Co-authorship network of co-authors of K. Gauger

This figure shows the co-authorship network connecting the top 25 collaborators of K. Gauger. A scholar is included among the top collaborators of K. Gauger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Gauger. K. Gauger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Janni, Wolfgang, Marion Kiechle, H. Sommer, et al.. (2006). Study participation improves treatment strategies and individual patient care in participating centers.. PubMed. 26(5B). 3661–7. 16 indexed citations
3.
Gauger, K., W Janni, Doris Augustin, et al.. (2005). Phase III study evaluating the role of docetaxel in the adjuvant setting of breast cancer patients with ≥ 4 involved lymph nodes: ADEBAR-Study. Journal of Clinical Oncology. 23(16_suppl). 908–908. 6 indexed citations
4.
Gauger, K., et al.. (2005). Antibody therapy for breast cancer.. PubMed. 25(3A). 1483–9. 26 indexed citations
5.
Janni, W, Marion Kiechle, Brigitte Rack, et al.. (2005). Participation in study improves treatment strategies and individual patient care in the participating centres. mediaTUM (Technical University of Munich). 65(10). 966–973. 1 indexed citations
7.
Kates, Ronald, K. Gauger, Marion Kiechle, et al.. (2004). Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1: novel tumor-derived factors with a high prognostic and predictive impact in breast cancer. Thrombosis and Haemostasis. 91(3). 450–456. 120 indexed citations
8.
Harbeck, Nadia, Ronald Kates, Manfred Schmitt, et al.. (2004). Urokinase-Type Plasminogen Activator and Its Inhibitor Type 1 Predict Disease Outcome and Therapy Response in Primary Breast Cancer. Clinical Breast Cancer. 5(5). 348–352. 74 indexed citations
9.
Lengyel, Ernst, Dieter Prechtel, James H. Resau, et al.. (2004). C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu. International Journal of Cancer. 113(4). 678–682. 217 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026